FX-11

Research use only, not for human use.

FX-11 (LDHA Inhibitor FX11) is A potent, selective and competitive specific inhibitor of lactate dehydrogenase A (LDHA) with a Ki of 8 μM. FX-11 can activate PKM2 (pyruvate kinase M2).

FX-11 is a potent, selective, reversible and competitive lactate dehydrogenase A (LDHA) inhibitor, with a Ki of 8 μM. FX-11 reduces ATP levels and induces oxidative stress, ROS production and cell death. FX-11 shows antitumor activity in lymphoma and pancreatic cancer xenografts.

Western Blot Analysis Cell Line:P493 cellsConcentration:9 μM Incubation Time:24 h, 48 h Result:Showed a decrease in ATP levels, accompanied by activation of AMP kinase and phosphorylation of its substrate acetyl-CoA carboxylase.Cell Proliferation Assay Cell Line:BxPc-3 and MIA PaCa-2 cells Concentration:0-100 μM Incubation Time:72 h Result:Reduced cell metabolic activity in a concentration-dependent manner, showed a significant reduction in cell proliferation, with IC50 values of 49.27 μM and 60.54 μM for BxPc-3 and MIA PaCa-2 cells, respectively.

Animal Model:Male SCID mice and RH-Foxn1nu mice (human P493 B-cell xenografts)Dosage:42 μg/mouse (2.1 mg/kg) Administration:IP; daily for 10-14 daysResult:Resulted in a remarkable inhibition of tumor growth, inhibited tumor xenograft progression.Animal Model:Immunocompromised CD-1 mice (6-8 weeks; 20-25 g, n=5 per group )Dosage:2 mg/kg, 1 mg/kg+15 mg/kg TEPP-46, 2 mg/kg+30 mg/kg TEPP-46 Administration:IP (100 μL), daily, for 3 weeks Result:Significantly lowered LDHA activity in plasma and tumor lysates; significantly lowered the expression of the proliferation marker Ki-67; significantly decreased proliferation indices were observed in tumor sections; significantly delayed tumor growth.

——

Metabolic Enzyme/Protease

Dehydrogenase

Dehydrogenase

——

——

213971-34-7

350.41

C22H22O4

>98% (HPLC)

In Vitro:?DMSO : 250 mg/mL (713.45 mM; Ultrasonic )

CCCc1c(O)c(O)c(C(O)=O)c2cc(Cc3ccccc3)c(C)cc12

——

(-20℃)

With Ice Pack

≥ 2 years